GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » Other Financing

Frontage Holdings (HKSE:01521) Other Financing : HK$-64 Mil (TTM As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings Other Financing?

Frontage Holdings's Other Financing for the six months ended in Jun. 2024 was HK$-34 Mil.

Frontage Holdings's Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-64 Mil.

Frontage Holdings Other Financing Historical Data

The historical data trend for Frontage Holdings's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontage Holdings Other Financing Chart

Frontage Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial -87.49 -17.02 -20.11 -33.62 -55.23

Frontage Holdings Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.11 -22.60 -24.36 -30.94 -33.55

Frontage Holdings Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frontage Holdings Other Financing Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontage Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » Other Financing
Comparable Companies
HKSE:02257 HKSE:01167 HKSE:01477 HKSE:02179 HKSE:02616 HKSE:01244 HKSE:01873 HKSE:06622 HKSE:02171 HKSE:02496 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
700 Pennsylvania Drive, Exton, PA, USA, 19341
Website
https://www.frontagelab.com
Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical, and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include drug discovery, drug development, pharmaceutical product development, and laboratory testing in the USA and Canada; and the PRC segment includes the same services provided in the People's Republic of China. The company generates a majority of its revenue from USA followed by the PRC and the rest of the world.
Executives
Hang Zhou Tai Ge Yi Yao Ke Ji Gu Fen You Xian Gong Si 2101 Beneficial owner
Li Song 2101 Beneficial owner
Kabouter Management Llc 2102 Investment manager
Hangzhou Tigermed Consulting Co., Ltd.
Hongkong Tigermed Co., Limited

Frontage Holdings Headlines

No Headlines